Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Assets (2018 - 2025)

AVITA Medical's Non-Current Assets history spans 8 years, with the latest figure at $20.9 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 7.97% year-over-year to $20.9 million; the TTM value through Dec 2025 reached $86.7 million, up 31.21%, while the annual FY2025 figure was $20.9 million, 7.97% down from the prior year.
  • Non-Current Assets reached $20.9 million in Q4 2025 per RCEL's latest filing, down from $22.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $24.0 million in Q3 2021 to a low of $4.2 million in Q2 2021.
  • Average Non-Current Assets over 5 years is $14.4 million, with a median of $13.1 million recorded in 2024.
  • Peak YoY movement for Non-Current Assets: skyrocketed 519.53% in 2021, then tumbled 65.84% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $23.9 million in 2021, then crashed by 54.75% to $10.8 million in 2022, then dropped by 29.35% to $7.6 million in 2023, then surged by 197.5% to $22.7 million in 2024, then fell by 7.97% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Non-Current Assets are $20.9 million (Q4 2025), $22.4 million (Q3 2025), and $21.9 million (Q2 2025).